| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Oncolytics Biotech Inc (TSE: ONC)
ONC Technical Analysis
1.5
| As on 31st Oct 2017 ONC Share Price closed @ 0.57 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.52 & Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ONC Share Price
| Open | 0.54 | Change | Price | % |
| High | 0.57 | 1 Day | 0.01 | 1.79 |
| Low | 0.54 | 1 Week | 0.00 | 0.00 |
| Close | 0.57 | 1 Month | -0.03 | -5.00 |
| Volume | 112035 | 1 Year | 0.31 | 119.23 |
| 52 Week High 1.13 | 52 Week Low 0.19 | ||||
TSE Canada Most Active Stocks
| BIN | 41.40 | -1.62% |
| LSG | 2.08 | 8.33% |
| TBE | 0.03 | 0.00% |
| ECA | 15.09 | 4.43% |
| SC | 60.83 | -0.44% |
| PRE | 0.64 | 0.00% |
| ELD | 1.62 | -6.90% |
| MFC | 25.94 | -0.04% |
| CPG | 10.61 | 4.53% |
| BBD-B | 2.73 | -1.09% |
TSE Canada Top Gainers Stocks
TSE Canada Top Losers Stocks
| ONC Daily Charts |
ONC Intraday Charts |
Whats New @ Bazaartrend |
ONC Free Analysis |
|
|
ONC Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 0.60 |
| RESISTANCE | 0.59 |
| SUPPORT | 0.55 |
| SUPPORT | 0.54 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
ONC Target for Month January
| 4th UP TARGET | 0.82 |
| 3rd UP TARGET | 0.74 |
| 2nd UP TARGET | 0.69 |
| 1st UP TARGET | 0.64 |
| 1st DOWN TARGET | 0.5 |
| 2nd DOWN TARGET | 0.45 |
| 3rd DOWN TARGET | 0.4 |
| 4th DOWN TARGET | 0.32 |
ONC Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
ONC Target for Year 2021
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
Oncolytics Biotech Inc ( TSE Canada Symbol : ONC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
